1. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA)
   Karthik Reddy Kami Reddy et al, 2018, Angiogenesis CrossRef
2. Cell Cycle Inhibition without Disruption of Neurogenesis Is a Strategy for Treatment of Aberrant Cell Cycle Diseases: An Update
   Da-Zhi Liu et al, 2012, The Scientific World Journal CrossRef
3. Novel Cellularly Active Inhibitor Regresses DDAH1 Induced Prostate Tumor Growth by Restraining Tumor Angiogenesis through Targeting DDAH1/ADMA/NOS Pathway
   Karthik Reddy Kami Reddy et al, 2019, ACS Combinatorial Science CrossRef
4. DNA methylation markers for risk of metastasis in a cohort of men with localized prostate cancer
   Talar S. Habeshian et al, 2024, Epigenetics CrossRef